CORXEL (formerly Ji Xing) acquired the rights to develop and commercialize aficamten in Greater China (including the Chinese ...
Journal of the American College of Cardiology: "2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy." This heart condition makes it hard for the ...
Classically, hypertrophic cardiomyopathy (HCM) has been viewed as a single-gene (monogenic ... We hypothesize that LowSVs may be common in HCM with substantial influence on disease risk and severity.
Dilated cardiomyopathy (DCM) is a heterogeneous disorder that is familial in approximately 30% of cases. Although several genes have been identified that can cause familial DCM, molecular analyses ...
View all available purchase options and get full access to this article.
“Hypertrophic cardiomyopathy can be an insidious disease, with some people having no obvious symptoms, while others may only feel symptoms with exercise or exertion,” said Andrew Wang, M.D., FAHA, ...
Acoramidis (Attruby; BridgeBio), a drug that stabilizes transthyretin and has demonstrated benefit on cardiovascular outcomes, has been approved by the US Food and Drug Administration for the ...
American Heart Association volunteer, co-chair of the Association's HCM Science Advisory Group and president of the Hypertrophic Cardiomyopathy Medical Society , a collaborator on the initiative.
Classification can be performed on structured or unstructured data. Classification is a technique where we categorize data into a given number of classes. The main goal of a classification problem is ...
Oussama Wazni, MD, Cleveland Clinic, discusses insights from the OPTION trial and their potential implication on guidelines for post-ablation management in atrial fibrillation.
As academic director for Duke University's corporate education business, Cheryl Stokes traveled the globe. Doing so while 4 months pregnant meant enduring more discomfort than usual.